RU2007121705A - ANTI-INFECTIOUS LIPOPEPTIDES - Google Patents
ANTI-INFECTIOUS LIPOPEPTIDES Download PDFInfo
- Publication number
- RU2007121705A RU2007121705A RU2007121705/04A RU2007121705A RU2007121705A RU 2007121705 A RU2007121705 A RU 2007121705A RU 2007121705/04 A RU2007121705/04 A RU 2007121705/04A RU 2007121705 A RU2007121705 A RU 2007121705A RU 2007121705 A RU2007121705 A RU 2007121705A
- Authority
- RU
- Russia
- Prior art keywords
- amino
- composition
- composition according
- compound
- protecting group
- Prior art date
Links
- ISWMPZKCFGUBPJ-UHFFFAOYSA-N CCC(c(cccc1)c1N)=O Chemical compound CCC(c(cccc1)c1N)=O ISWMPZKCFGUBPJ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Abstract
1. Композиция, содержащая соединение формулы F2и его соли; гдеa) Rпредставляет собой водород, метил,,или;b) Rпредставляет собой Н или СН;c) Rпредставляет собой СН(СН), СН(СНСН)СН,или;иd) каждый из R, Rи Rнезависимо представляет собой амино, монозамещенную амино, дизамещенную амино, NH-аминозащитную группу, ациламино, уреидо, гуанидино, карбамоил, сульфонамино, тиоациламино, тиоуреидо, иминоамино или фосфонамино.2. Композиция по п.1, где каждый из Rи Rнезависимо представляет собой амино, NH-аминозащитную группу или карбамоил.3. Композиция по п.2, где каждый из Rи Rнезависимо представляет собой амино.4. Композиция по п.1, где Rпредставляет собой амино, алканоиламино, NH-аминозащитную группу.5. Композиция по п.4, где Rпредставляет собой С-Салканоиламино.6. Композиция по п.5, где Rпредставляет собой,,,или7. Композиция по п.1, выбранная изили8. Композиция по п.1, выбранная изили9. Композиция, содержащая соединение формулы F9и его соли; гдеa) Rпредставляет собой Н или СН; иb) каждый из Rи Rнезависимо представляет собой амино, монозамещенную амино, дизамещенную амино, NH-аминозащитную группу, ациламино, уреидо, гуанидино, карбамоил, сульфонамино, тиоациламино, тиоуреидо, иминоамино или фосфонамино.10. Композиция по п.9, где Rпредставляет собой амино, NH-аминозащитную группу или карбамоил.11. Композиция по п.10, где Rпредставляет собой амино.12. Композиция по п.9, где Rпредставляет собой амино, алканоиламино, NH-аминозащитную группу.13. Композиция по п.12, где Rпредставляет собой С-Салканоиламино.14. Композиция по п.13, где Rпредставляет собой,,,или15. Композиция по п.9, где Rпредставляет собой СН.16. Композиция по п.15, где Rпредставляет собой алканоиламино.17. Композиция по п.16, где R�1. A composition comprising a compound of formula F2 and a salt thereof; where a) R is hydrogen, methyl, or; b) R is H or CH; c) R is CH (CH), CH (CHCH) CH, or; and d) each of R, R and R is independently amino, monosubstituted amino a disubstituted amino, NH-amino protecting group, acylamino, ureido, guanidino, carbamoyl, sulfonamino, thioacylamino, thioureido, iminoamino or phosphonamino. 2. The composition according to claim 1, wherein each of R and R is independently an amino, NH-amino-protecting group or carbamoyl. The composition of claim 2, wherein each of R and R is independently amino. The composition of claim 1, wherein R1 is an amino, alkanoylamino, NH-amino protecting group. The composition of claim 4, wherein R is C-Salcanoylamino. The composition of claim 5, wherein R is ,,, or 7. The composition according to claim 1, selected or 8. The composition according to claim 1, selected or 9. A composition comprising a compound of formula F9 and a salt thereof; where a) R is H or CH; and b) each of R and R is independently an amino, monosubstituted amino, disubstituted amino, NH amino protecting group, acylamino, ureido, guanidino, carbamoyl, sulfonamino, thioacylamino, thioureido, iminoamino or phosphonamino. 10. The composition of claim 9, wherein R1 is an amino, NH-amino protecting group or carbamoyl. The composition of claim 10, wherein R4 is amino. The composition of claim 9, wherein R1 is an amino, alkanoylamino, NH-amino protecting group. The composition of claim 12, wherein R1 is C-Salkanoylamino. The composition of claim 13, wherein R is ,,, or 15. The composition of claim 9, wherein R1 is CH.16. The composition of claim 15, wherein R is alkanoylamino. The composition of claim 16, where R�
Claims (43)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62705604P | 2004-11-12 | 2004-11-12 | |
US60/627,056 | 2004-11-12 | ||
US71070505P | 2005-08-23 | 2005-08-23 | |
US60/710,705 | 2005-08-23 | ||
PCT/US2005/040919 WO2006110185A2 (en) | 2004-11-12 | 2005-11-11 | Antiinfective lipopeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2007121705A true RU2007121705A (en) | 2008-12-20 |
Family
ID=37087468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007121705/04A RU2007121705A (en) | 2004-11-12 | 2005-11-11 | ANTI-INFECTIOUS LIPOPEPTIDES |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1814588A2 (en) |
JP (1) | JP2008519848A (en) |
KR (1) | KR20070086038A (en) |
AU (1) | AU2005330517A1 (en) |
BR (1) | BRPI0517830A (en) |
CA (1) | CA2587848A1 (en) |
IL (1) | IL183109A0 (en) |
NO (1) | NO20072634L (en) |
RU (1) | RU2007121705A (en) |
WO (1) | WO2006110185A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2512396C2 (en) * | 2008-12-22 | 2014-04-10 | Кьюбист Фармасьютикалз, Инк. | Novel antibacterial medications for treatment of gram-positive infections |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012162567A1 (en) * | 2011-05-26 | 2012-11-29 | Cubist Pharmaceuticals, Inc. | Cb-183,315 compositions and related methods |
KR101723649B1 (en) | 2014-10-23 | 2017-04-06 | 서울대학교산학협력단 | Novel peptide compound, a preparing method thereof, and a use thereof |
CN113061164B (en) * | 2021-03-29 | 2023-01-10 | 四川大学 | Cyclic lipopeptide compound and application thereof in anti-rheumatoid arthritis drugs |
WO2023152229A1 (en) * | 2022-02-09 | 2023-08-17 | Teitur Trophics Aps | Novel peptides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0016467A (en) * | 1999-12-15 | 2002-08-27 | Cubist Pharm Inc | Lipopeptides as antibacterial agents |
AU784755B2 (en) * | 1999-12-15 | 2006-06-08 | Merck Sharp & Dohme Corp. | Daptomycin Analogs as antibacterial agents |
JP2003517003A (en) * | 1999-12-15 | 2003-05-20 | キュービスト ファーマシューティカルズ, インコーポレイテッド | Daptomycin analogs and their use as antibacterial agents |
DE60232158D1 (en) * | 2001-08-06 | 2009-06-10 | Cubist Pharm Inc | LIPOPEPTIDE STEREOISOMERS, METHOD FOR THEIR PRODUCTION AND USEFUL INTERMEDIATE PRODUCTS |
EP1421097A4 (en) * | 2001-08-06 | 2005-07-06 | Cubist Pharm Inc | Compositions and methods relating to the daptomycin biosynthetic gene cluster |
-
2005
- 2005-11-11 RU RU2007121705/04A patent/RU2007121705A/en not_active Application Discontinuation
- 2005-11-11 AU AU2005330517A patent/AU2005330517A1/en not_active Abandoned
- 2005-11-11 JP JP2007541346A patent/JP2008519848A/en not_active Withdrawn
- 2005-11-11 CA CA002587848A patent/CA2587848A1/en not_active Abandoned
- 2005-11-11 BR BRPI0517830-4A patent/BRPI0517830A/en not_active IP Right Cessation
- 2005-11-11 KR KR1020077013150A patent/KR20070086038A/en not_active Application Discontinuation
- 2005-11-11 EP EP05857738A patent/EP1814588A2/en not_active Withdrawn
- 2005-11-11 WO PCT/US2005/040919 patent/WO2006110185A2/en active Application Filing
-
2007
- 2007-05-10 IL IL183109A patent/IL183109A0/en unknown
- 2007-05-24 NO NO20072634A patent/NO20072634L/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2512396C2 (en) * | 2008-12-22 | 2014-04-10 | Кьюбист Фармасьютикалз, Инк. | Novel antibacterial medications for treatment of gram-positive infections |
Also Published As
Publication number | Publication date |
---|---|
JP2008519848A (en) | 2008-06-12 |
CA2587848A1 (en) | 2006-10-19 |
WO2006110185A3 (en) | 2007-10-25 |
IL183109A0 (en) | 2008-04-13 |
EP1814588A2 (en) | 2007-08-08 |
KR20070086038A (en) | 2007-08-27 |
NO20072634L (en) | 2007-08-09 |
AU2005330517A1 (en) | 2006-10-19 |
WO2006110185A2 (en) | 2006-10-19 |
AU2005330517A2 (en) | 2006-10-19 |
BRPI0517830A (en) | 2008-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2327701C2 (en) | Nucleoside derivatives and pharmaceutical composition, with antiviral activity to hcv | |
RU2342367C2 (en) | Non-nucleozide inhibitors i of reverse transcriptase, intended for treatment of hiv-mediated diseases | |
RU2009102252A (en) | HINOXALINYL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS VIRUS SERIN PROTEASE | |
TW200510391A (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
EP2341065A3 (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4a protease | |
RU2007123235A (en) | ANTITUMOR COMPOUNDS | |
NZ531493A (en) | Novel depsipeptides and process for preparing same, useful in the treatment of bacterial infection | |
RU2008119842A (en) | TRIAZOLE DERIVATIVES AS 11-BETA-HYDROXISTEROID-DEHYDROHENASE-1 INHIBITORS | |
RU2007136535A (en) | PEPTIDOMIMETIC COMPOUNDS AND OBTAINING BIOLOGICALLY ACTIVE DERIVATIVES | |
CA2405521A1 (en) | Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties | |
RU2009102832A (en) | C-Phenyl-1-Tyloglucytols | |
RU2006118789A (en) | 2-Cyanopyrrolidinecarboxamide compound | |
RU2450015C2 (en) | Aminothiazole derivatives and application thereof as antibacterial agents | |
RU2007121705A (en) | ANTI-INFECTIOUS LIPOPEPTIDES | |
DE69727956D1 (en) | PHARMACEUTICAL PREPARATIONS FOR REDUCING BREATHING DEPRESSIONS | |
PE20050420A1 (en) | PHENACILO 2-HYDROXY-3-DIAMINOALKANOS | |
RU2005105576A (en) | Pleuromutilin derivatives as antimicrobial agents | |
WO2002089782A3 (en) | Dioxanes and uses thereof | |
JP2004530699A5 (en) | ||
RU2003134629A (en) | CEPHEMA COMPOUNDS | |
RU2009111387A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FUNGAL INFECTIONS | |
JP2008519848A5 (en) | ||
RU2003130070A (en) | BIGUANID DERIVATIVES | |
DE69315836D1 (en) | PYRAZOLPYRIDINE FOR TREATING ANEMIA | |
DE602005017629D1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEISHMANIASIS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20100310 |